Leading Law Firm ROSEN Encourages Lost Investors of Reata Pharmaceuticals, Inc. to Get Attorney’s Protection Ahead of Important Securities Class Action Deadline – RETA – QNT Press Release

NEW YORK, January 16, 2022 (GLOBE NEWSWIRE) — Why: Rosen LLP, a global investor rights law firm, reminds buyers to buy Reata Pharmaceuticals, Inc. (NASDAQ:straight) from November 9, 2020 to December 8, 2021 (inclusive) (“Class Period”), February 18, 2022 lead plaintiff deadline.

So: If you purchased Reata Pharmaceuticals securities during a class action, you may be entitled to compensation through a contingency fee arrangement without any out-of-pocket costs or costs.

What to do next: To join the Reata Pharmaceuticals class action, visit http://www.rosenlegal.com/cases-register-2230.html Or call Phillip Kim, Esq.Toll Free 866-767-3653 or email [email protected] or [email protected] Information on class action lawsuits. A class action lawsuit has been filed.If you wish to be the lead plaintiff, you must move the court No later than February 18, 2022. The lead plaintiff is the representative party directing the litigation on behalf of the other class members.

Why choose the Rosen method: We encourage investors to choose qualified attorneys with a track record of successful leadership…

The full story is available on Benzinga.com

Source link

Recommended For You

About the Author: News Center